Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
AbbVie Inc

ABBV

AbbVie Inc

AbbVie Inc 13F Holders

ABBV Stock Ownership Activity

# of activities:
4
AVG reported price*:
$134.73
Current price*:
+91.14%($257.52)
4 value investing gurus have made changes to the AbbVie Inc (ABBV) position according to the gurus' 2023 Q2 SEC quarterly report(s). ABBV has been bought (as a new position) by 1 guru(s), the number of ABBV shares has been increased by 1, decreased by 2 super investor(s).

Which gurus or hedge funds bought ABBV in 2023 Q2?

According to the 2023 Q2 SEC filing(s) AbbVie Inc (ABBV) has been bought by 2 gurus / funds: Sarah Ketterer - Causeway Capital Management (new buy) and David Katz - Matrix Advisors Value Fund (added shares +1.87%).
To see more about who is investing in AbbVie Inc (ABBV), please go to the ABBV ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.